Literature DB >> 17573829

Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: data from a single institute over 30 years.

Ryoji Miyahara1, Yasumasa Niwa, Tetsuo Matsuura, Osamu Maeda, Takafumi Ando, Naoki Ohmiya, Akihiro Itoh, Yoshiki Hirooka, Hidemi Goto.   

Abstract

BACKGROUND AND AIM: In Japan, screening examination with photofluorography is widely performed to reduce the mortality due to gastric cancer. The possibility of a future decline in gastric cancer cases and changes in its characteristics is suggested. The aim of this study was to examine the usefulness of direct radiology as a general health screening technique and the historical changes of gastric cancer in Japan.
METHODS: This study involved 936 patients with gastric cancer whose carcinomas were detected by direct radiology as part of a general health screening at the Aichi Prefectural Center for Health Care from 1970 to 2000. We studied the prevalence of gastric carcinoma, its prognosis, differences between the two histological types of carcinoma and historical changes.
RESULTS: The age-adjusted cancer detection rate slightly decreased. Comparing two histological types, diffuse-type carcinoma cases relatively increased. Intestinal-type carcinomas increased in the lower portion of the stomach, whereas diffuse-type increased in the upper portion. The 5-year survival rate was 92.7% for intestinal-type carcinoma and 84.8% for diffuse-type. Diffuse-type carcinomas were further progressed than intestinal-type when detected by direct radiology; however, detection of diffuse-type improved, so the percentage of early gastric cancer of diffuse type significantly increased, and the survival rate significantly improved, from 70.4% to 90.5%.
CONCLUSION: The prevalence of gastric cancer has been decreasing, but the proportion of diffuse-type carcinoma localized in the upper portion of the stomach has been increasing in Japan.

Entities:  

Mesh:

Year:  2007        PMID: 17573829     DOI: 10.1111/j.1440-1746.2007.04991.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  31 in total

1.  Defining a high-risk subgroup of pathological T2N0 gastric cancer by prognostic risk stratification for adjuvant therapy.

Authors:  Chunyan Du; Ye Zhou; Kai Huang; Guangfa Zhao; Hong Fu; Yingqiang Shi
Journal:  J Gastrointest Surg       Date:  2011-09-22       Impact factor: 3.452

Review 2.  How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.

Authors:  Christina Kim; Karen Mulder; Jennifer Spratlin
Journal:  Oncologist       Date:  2014-08-20

3.  Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.

Authors:  Chun-Yan Du; Jing-Gui Chen; Ye Zhou; Guang-Fa Zhao; Hong Fu; Xue-Ke Zhou; Ying-Qiang Shi
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

4.  Helicobacter pylori Infection and Gastric Adenocarcinoma.

Authors:  Pelayo Correa; M Blanca Piazuelo
Journal:  US Gastroenterol Hepatol Rev       Date:  2011-06

5.  No association of vascular endothelial growth factor-A (VEGF-A) and VEGF-C expression with survival in patients with gastric cancer.

Authors:  Soo Jung Lee; Jong Gwang Kim; Sang Kyun Sohn; Yee Soo Chae; Joon Ho Moon; Shi Nae Kim; Han-Ik Bae; Ho Young Chung; Wansik Yu
Journal:  Cancer Res Treat       Date:  2009-12-31       Impact factor: 4.679

6.  Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers.

Authors:  Kangkang Zhi; Xiaojun Shen; Hao Zhang; Jianwei Bi
Journal:  J Exp Clin Cancer Res       Date:  2010-06-08

7.  Clinical significance of integrin αvβ6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts.

Authors:  Zhuonan Zhuang; Ruiling Zhou; Xiaozhou Xu; Tian Tian; Yi Liu; Yanfeng Liu; Peilong Lian; Jiayong Wang; Kesen Xu
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

8.  Measurement of circulating levels of VEGF-A, -C, and -D and their receptors, VEGFR-1 and -2 in gastric adenocarcinoma.

Authors:  Mansour-S Al-Moundhri; A Al-Shukaili; M Al-Nabhani; B Al-Bahrani; I-A Burney; A Rizivi; S-S Ganguly
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 9.  Gastric cancer: overview.

Authors:  Pelayo Correa
Journal:  Gastroenterol Clin North Am       Date:  2013-02-21       Impact factor: 3.806

10.  Clinicopathologic characteristics and survival outcomes of patients with advanced esophageal, gastroesophageal junction, and gastric adenocarcinoma: a single-institution experience.

Authors:  A Dechaphunkul; K Mulder; F El-Gehani; S Ghosh; J Deschenes; J Spratlin
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.